LC
AGL icon

Lindbrook Capital’s Agilon Health AGL Stock Holding History

Lindbrook Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$20.6K Buy
190
+80
+73% +$6.96K ﹤0.01% 1338
2024
Q4 		$5.25K Buy
110
+80
+267% +$4.84K ﹤0.01% 1960
2024
Q3 		$2.93K Sell
30
-77
-72% -$9.94K ﹤0.01% 2229
2024
Q2 		$17.5K Buy
107
+45
+73% +$6.41K ﹤0.01% 1321
2024
Q1 		$9.47K Buy
62
+49
+377% +$8.15K ﹤0.01% 1605
2023
Q4 		$4.17K Buy
13
+12
+1,200% +$4.34K ﹤0.01% 1983
2023
Q3 		$622 Hold
1
– – ﹤0.01% 2486
2023
Q2 		$555 Sell
1
-7
-88% -$3.93K ﹤0.01% 2489
2023
Q1 		$4.56K Buy
+8
New +$4.48K ﹤0.01% 1892
2022
Q4 		– Hold
0
– – – 2825
2022
Q3 		– Hold
0
– – – 2599

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lindbrook Capital's AGL Position: Q1 2025 in Review

Lindbrook Capital increased its Agilon Health (AGL) stake by 73% in Q1 2025, buying an estimated $6.96K and bringing the position to 190 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Lindbrook Capital first reported a position in AGL in Q1 2023 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold AGL as of Q1 2025.

  • Lindbrook Capital held 190 shares of Agilon Health worth $20.6K as of Q1 2025.
  • Lindbrook Capital bought 80 Agilon Health shares in Q1 2025, an estimated $6.96K.
  • Agilon Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1338 holding.
  • Lindbrook Capital first reported a position in Agilon Health in Q1 2023 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held Agilon Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.